These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 21645960)

  • 1. PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.
    Jiang M; Strand DW; Franco OE; Clark PE; Hayward SW
    Differentiation; 2011; 82(4-5):220-36. PubMed ID: 21645960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens and estrogens in benign prostatic hyperplasia: past, present and future.
    Nicholson TM; Ricke WA
    Differentiation; 2011; 82(4-5):184-99. PubMed ID: 21620560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interleukins, IGF and stem cells in BPH.
    McLaren ID; Jerde TJ; Bushman W
    Differentiation; 2011; 82(4-5):237-43. PubMed ID: 21864972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.
    Vignozzi L; Gacci M; Cellai I; Morelli A; Maneschi E; Comeglio P; Santi R; Filippi S; Sebastianelli A; Nesi G; Serni S; Carini M; Maggi M
    Prostate; 2013 Sep; 73(13):1391-402. PubMed ID: 23765639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines and BPH/LUTS.
    Macoska JA
    Differentiation; 2011; 82(4-5):253-60. PubMed ID: 21600689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia.
    Wang Z; Olumi AF
    Differentiation; 2011; 82(4-5):261-71. PubMed ID: 21536370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging-Related Mitochondrial Dysfunction Is Associated With Fibrosis in Benign Prostatic Hyperplasia.
    Adrian AE; Liu TT; Pascal LE; Bauer SR; DeFranco DB; Ricke WA
    J Gerontol A Biol Sci Med Sci; 2024 Jun; 79(6):. PubMed ID: 37738211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of prostate peripheral zone thickness with benign prostatic hyperplasia/ lower urinary tract symptoms: An update].
    Kong B; Hou X; Yang JY
    Zhonghua Nan Ke Xue; 2019 Aug; 25(8):744-748. PubMed ID: 32227720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia and insulin resistance and the risk of BPH/LUTS: an update of recent literature.
    Breyer BN; Sarma AV
    Curr Urol Rep; 2014 Dec; 15(12):462. PubMed ID: 25287259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction.
    Calogero AE; Burgio G; Condorelli RA; Cannarella R; La Vignera S
    Aging Male; 2019 Mar; 22(1):12-19. PubMed ID: 29392976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms.
    Russo GI; Castelli T; Privitera S; Fragalà E; Favilla V; Reale G; Urzì D; La Vignera S; Condorelli RA; Calogero AE; Cimino S; Morgia G
    BJU Int; 2015 Nov; 116(5):791-6. PubMed ID: 25601421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.
    Tyagi P; Motley SS; Kashyap M; Pore S; Gingrich J; Wang Z; Yoshimura N; Fowke JH
    Int Urol Nephrol; 2015 Jul; 47(7):1051-8. PubMed ID: 25924782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes.
    Caretta N; Vigili de Kreutzenberg S; Valente U; Guarneri G; Pizzol D; Ferlin A; Avogaro A; Foresta C
    Andrology; 2015 Nov; 3(6):1062-7. PubMed ID: 26339755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.
    Gacci M; Vignozzi L; Sebastianelli A; Salvi M; Giannessi C; De Nunzio C; Tubaro A; Corona G; Rastrelli G; Santi R; Nesi G; Serni S; Carini M; Maggi M
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.
    Inamura S; Ito H; Shinagawa T; Tsutsumiuchi M; Taga M; Kobayashi M; Yokoyama O
    Prostate; 2018 Jul; 78(10):743-752. PubMed ID: 29608020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrinology of the Aging Prostate: Current Concepts.
    Cannarella R; Condorelli RA; Barbagallo F; La Vignera S; Calogero AE
    Front Endocrinol (Lausanne); 2021; 12():554078. PubMed ID: 33692752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.
    Vignozzi L; Gacci M; Maggi M
    Nat Rev Urol; 2016 Feb; 13(2):108-19. PubMed ID: 26754190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.